the Platform to conduct research on critical topics, introduce the results of relevant research into the Company's tumor clinical treatment system, and improve the development of Shineco's digital tumor diagnosis and treatment.
Both Shineco and JSY are poised to seize these opportunities to increase market share in the innovative drug and medical device industry by relying on their business advantages and their synergy cooperation.
Professor Sun will lead the research and innovation of the company’s tumor treatment and provide technical consultation in early tumor screening and tumor radiotherapy to support the commercialization of digital tumor diagnosis and treatment.
On Tuesday, Yoshitsu Co., Ltd, a Japanese beauty and health products retailer and wholesaler, debuted on the Nasdaq Stock Exchange under the ticker symbol “TKLF”, raising $25 million in its initial public offering (IPO).
While Didi Global's (ticker: DIDI) $4.4 billion IPO was big enough to stand out in the U.S. markets, another China-based company Pop Culture Group (ticker: CPOP) skyrocketed 405% to win the best first-day performance on Wednesday.